Welcome to AiCuris: The Powerhouse for Anti-Infectives
AiCuris (from 'Anti-infective Cures') is a pharmaceutical company focused exclusively on the discovery, research and development of novel antiviral and antibacterial agents for the treatment of severe and potentially life-threatening infectious diseases.
Founded in 2006 from Bayer's virology and bacteriology research divisions, AiCuris has a broad and innovative pipeline of novel anti-infectives and a team of internationally regarded scientists and drug developers. With its focus on specialist markets with high medical need, the company is perfectly positioned for growth and success.
AiCuris at ICAAC San Diego
Holger Zimmermann at 55th ICAAC in San Diego
AiCuris CEO Dr. Holger Zimmermann will be at ICAAC in San Diego.
For meeting arrangements please contact us.
Prof. Ruebsamen-Schaeff honored with “IUPAC Award”
Prof. Helga Rübsamen-Schaeff, founding CEO and as of March Chair of the Scientific Advisory Board of Wuppertal-based Biotech AiCuris has been honored with the "IUPAC Award".
Join AiCuris and its quest for novel Anti-Infectives
We offer an exciting and challenging working enviroment in an innovative company with a world-class R&D Portfolio.